AMH Fertility Test (Ovarian Reserve)

A self-pay Anti-Müllerian Hormone (AMH) blood test at the Zlín poliklinika collection point. AMH levels reflect the number of remaining eggs and give an estimate of ovarian reserve, helping women understand their current fertility window. Not covered by public insurance; offered as self-pay with no referral required and payment at the draw.

As women age, both the number and quality of eggs decline, and the chance of conceiving falls — a process that begins to accelerate from around age 30. Anti-Müllerian Hormone (AMH) is produced in relation to the pool of remaining eggs, so its level in the blood gives an estimate of ovarian reserve, sometimes described as the 'biological age' of the ovaries. **What the result means:** An AMH level within the expected range suggests an adequate egg reserve and optimal fertility for that age; a falling level reflects a declining reserve and a lower probability of conception; very low levels suggest fertility is nearing its end. AMH is therefore a useful prognostic indicator of where a woman stands in her fertility window, and is often used when planning the timing of pregnancy or before fertility treatment. **How it works:** Attend the Zlín poliklinika collection point during morning collection hours. AMH can be measured at any point in the menstrual cycle. A laboratory nurse takes a venous sample and payment is made at the draw, since AMH is not covered by Czech public health insurance. Results return through the laboratory's standard channels and should be interpreted together with a gynaecologist or fertility specialist. **Who it suits:** Women considering delaying pregnancy, those wanting reassurance about their fertility window, and anyone preparing for fertility treatment or planning ahead.